These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9627345)

  • 1. Reproducibility of technetium-99m-MAG3 clearance using the Bubeck method.
    Werner E; Blasl C; Reiners C
    J Nucl Med; 1998 Jun; 39(6):1066-9. PubMed ID: 9627345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance in patients with impaired renal function.
    Erdil TY; Dede F; Tuglular S; Sen F; Ones T; Farsakoglu Z; Inanir S; Ozener C; Akoglu E; Turoglu T
    Nucl Med Commun; 2006 Feb; 27(2):191-6. PubMed ID: 16404234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-mercaptoacetyltriglycine camera-based measurement of renal clearance: should the result be normalized for body surface area?
    Klingensmith WC
    J Nucl Med Technol; 2013 Dec; 41(4):279-82. PubMed ID: 24167023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate.
    Russell CD; Dubovsky EV
    J Nucl Med; 1999 Jul; 40(7):1122-4. PubMed ID: 10405130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility of a single-sample method for 99Tcm-MAG3 clearance under clinical conditions.
    Kotzerke J; Glatz S; Grillenberger K; Kleinschmidt K; Reske SN
    Nucl Med Commun; 1997 Apr; 18(4):352-7. PubMed ID: 9170621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney function after nephrectomy for renal cell carcinoma.
    Shirasaki Y; Tsushima T; Saika T; Nasu Y; Kumon H
    Urology; 2004 Jul; 64(1):43-7; discussion 48. PubMed ID: 15245931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance.
    Taylor A; Manatunga A; Morton K; Reese L; Prato FS; Greenberg E; Folks R; Kemp BJ; Jones ME; Corrigan PE; Galt J; Eshima L
    Radiology; 1997 Jul; 204(1):47-54. PubMed ID: 9205222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
    Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
    J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of camera-based 99mTc-MAG3 and 24-hour creatinine clearances for evaluation of kidney function.
    Esteves FP; Halkar RK; Issa MM; Grant S; Taylor A
    AJR Am J Roentgenol; 2006 Sep; 187(3):W316-9. PubMed ID: 16928911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of radiofrequency ablation on individual renal function: assessment by technetium-99m mercaptoacetyltriglycine renal scintigraphy.
    Mukai T; Sato S; Iguchi T; Mimura H; Yasui K; Gobara H; Saika T; Nasu Y; Kumon H; Kanazawa S
    Acta Med Okayama; 2006 Apr; 60(2):85-91. PubMed ID: 16680184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance.
    Hamscho N; Wilhelm A; Döbert N; Menzel C; Gossmann J; Berner U; Zaplatnikov K; Scheuermann EH; Grünwald F
    Nuklearmedizin; 2005; 44(5):200-4. PubMed ID: 16395496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calculation of renal clearance by dynamic measurement of excreted activity].
    Hackstein N; Bauer R
    Nuklearmedizin; 1999; 38(2):43-8. PubMed ID: 10100230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring renal function: a prospective study comparing camera-based technetium-99m mercaptoacetyltriglycine clearance and creatinine clearance.
    Halkar R; Taylor A; Manatunga A; Issa MM; Myrick SE; Grant S; Shenvi NV
    Urology; 2007 Mar; 69(3):426-30. PubMed ID: 17382136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of Tc-99m MAG3 clearance using camera-based methods without blood sampling.
    Inoue Y; Ohtomo K
    Clin Nucl Med; 2011 Nov; 36(11):1012-6. PubMed ID: 21975390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of 99mTc-MAG3 clearance by single-sample methods and camera-based methods.
    Inoue Y; Yoshikawa K; Yokoyama I; Ohtomo K
    Ann Nucl Med; 2000 Oct; 14(5):329-32. PubMed ID: 11108160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m mercaptoacetyltriglycine clearance values in children with minimal renal disease: can a normal range be determined?
    Meyer G; Piepsz A; Kolinska J; Lepej J; Sixt R; Hahn K
    Eur J Nucl Med; 1998 Jul; 25(7):760-5. PubMed ID: 9662599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
    Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
    J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance.
    Piepsz A; Tondeur M; Kinthaert J; Ham HR
    Eur J Nucl Med; 1996 Feb; 23(2):195-8. PubMed ID: 8925855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative 99mTc-MAG3 renal uptake: reproducibility and accuracy.
    Piepsz A; Tondeur M; Ham H
    J Nucl Med; 1999 Jun; 40(6):972-6. PubMed ID: 10452313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.